BCAX
Bicara Therapeutics Inc.
$10.75
+$0.31(+2.97%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$569.64M
Volume
261.03K
52W Range
$7.80 - $28.09
Target Price
$33.00
Key Metrics Overview
| Market Cap | $569.64M | P/E Ratio | N/A |
| 52W High | $28.09 | 52W Low | $7.80 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 14.5% |
| Overall Score | 41 | Value Score | -- |
| Quality Score | -- | Technical Score | 41 |
Growth Analysis
| EPS Current Est | $-2.32 | EPS Next Est | $-2.71 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $10.75 | +3.0% | 261.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW